Select Page

Health

CSOFT’s health blog aims to provide insight into complex diseases, treatment options and regulatory developments, and other prevalent health issues people face today.
Home 9 HealthFirst 100 9 HealthPage 75

CFDA: The Face of Regulation in China

The China Food and Drug Administration (CFDA) was founded in 2013. Grown from the organization formally known as the State Food and Drug Administration (SFDA), the CFDA was created to combine multiple regulatory authorities into a singular regulation process for food...

read more

Why an In-Country Review (ICR) is So Important

An in-country review (ICR), also referred to as an in-house review, is an essential step in life science translations. With translations for industries such as medical, pharmaceuticals, and biotechnologies, accuracy is of the utmost importance. Generally, in-country...

read more

Clinical Trials in India

Several years ago, clinical trials in India were a booming business. After becoming fully compliant with TRIPS in 2005, India was seen as a favorable place to conduct clinical trials as they boast a huge genetically diverse population, as well as a multitude of...

read more

Life Science Interpretation in Clinical Settings

Site Title Value of Professional Interpretation Services In an ideal world, we would always be able to use bilingual clinicians in health settings, however, this is not always possible. With multiple languages spoken around the world, and as individuals relocate or...

read more

Lost in Translation – Missing the Target

We have all seen how translation blunders can be humorous at times. While some may be entertaining, others cause quite a stir. There are entire websites dedicated to pointing out these translation errors on objects such as clothing or signs. Equally, you can discover...

read more

Categories

ABOUT US

CSOFT Health Sciences has over 15 years of experience providing end-to-end translation and localization solutions for all stages of the product life cycle, from pre-clinical to post-launch. We also specialize in China market access consulting services, Asian regulatory and eCTD submissions. Our operation is compliant with ISO 17100 and certified by BSI in ISO 9001:2015 and ISO 13485:2016, providing customized solutions to meet the rigorous regulatory requirements in global submission. For more information, please visit: www.csoftintl.com